申科股份(002633) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 was ¥55,849,738.92, representing a 40.78% increase compared to ¥39,671,114.04 in the same period last year[3] - Net profit attributable to shareholders decreased by 1.73% to ¥1,083,781.62 from ¥1,102,865.66 year-on-year[3] - The net profit after deducting non-recurring gains and losses was ¥217,025.40, a significant increase of 105.81% compared to a loss of ¥3,737,303.53 in the previous year[3] - The company reported a significant increase in sales revenue, which was the main driver for the 40.78% growth in operating income[8] - Total revenue for the current period reached ¥55,849,738.92, an increase of 40.8% compared to ¥39,671,114.04 in the previous period[17] - Operating profit for Q1 2022 was CNY 973,175.76, down from CNY 1,145,404.61 in the same period last year, reflecting a decline of approximately 15%[18] - The total comprehensive income for Q1 2022 was CNY 1,083,781.62, slightly lower than CNY 1,102,865.66 in Q1 2021[19] Cash Flow and Liquidity - The net cash flow from operating activities improved by 107.73%, reaching ¥590,765.61, compared to a negative cash flow of ¥7,646,833.75 in the same period last year[3] - Cash flow from operating activities generated a net inflow of CNY 590,765.61, compared to a net outflow of CNY 7,646,833.75 in Q1 2021[22] - The company's cash and cash equivalents at the end of the period were ¥33,900,636.61, compared to ¥30,770,187.34 at the beginning of the year, indicating a growth of 6.9%[13] - Total cash and cash equivalents at the end of Q1 2022 were CNY 26,230,457.53, down from CNY 32,077,409.97 at the end of Q1 2021[23] - The company raised CNY 60,500,000.00 through borrowings in Q1 2022, with a net cash inflow from financing activities of CNY 4,654,573.65[23] Assets and Liabilities - Total assets at the end of the reporting period were ¥652,019,901.34, a decrease of 1.07% from ¥659,076,299.29 at the end of the previous year[3] - Total assets decreased to ¥652,019,901.34 from ¥659,076,299.29, a reduction of 1.1%[15] - Total liabilities decreased to ¥180,767,993.99 from ¥188,908,173.56, a decline of 4.4%[15] Shareholder Information - The company's equity attributable to shareholders increased slightly by 0.23% to ¥471,251,907.35 from ¥470,168,125.73 at the end of the previous year[3] - The company's equity attributable to shareholders increased to ¥471,251,907.35 from ¥470,168,125.73, a slight increase of 0.2%[15] - The number of common shareholders at the end of the reporting period was 9,798[10] - The top shareholder, He Quanbo, holds 28.12% of the shares, with a total of 42,187,466 shares[10] Expenses - Research and development expenses decreased by 51.21% to ¥217.56 million, primarily due to the completion of most R&D projects during the period[8] - Financial expenses surged by 330.81% to ¥143.03 million, attributed to increased bank loan interest[8] - Research and development expenses amounted to CNY 2,175,621.83, a significant decrease of 51% from CNY 4,459,435.12 in Q1 2021[18] - The company incurred financial expenses of CNY 1,430,326.05, which is a significant increase from CNY 331,979.28 in the same period last year[18] Operating Costs - Total operating costs amounted to ¥54,568,772.86, up from ¥43,699,751.83, reflecting a rise of 24.8%[17] - Accounts receivable increased to ¥131,027,834.42 from ¥119,511,079.04, representing a rise of 9.4%[13] - Inventory decreased slightly to ¥151,728,198.25 from ¥153,504,201.97, a decline of 1.2%[13]